2.56
2.56 (0%)
As of Feb 14, 2025
Macrogenics Inc [MGNX]
Source:
Company Overview
Macrogenics Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer. We generate our pipeline of product candidates from our proprietary suite of antibody technology platforms.
Country | United States |
Headquarters | rockville, maryland |
Phone Number | (301) 251-5172 |
Industry | manufacturing |
CEO | Scott Koenig |
Website | www.macrogenics.com |